Pre-earnings options volume in Protagonist Therapeutics is normal with puts leading calls 2:1. Implied volatility suggests the market is anticipating a move near 3.7%, or 92c, after results are released. Median move over the past eight quarters is 2.4%.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on PTGX:
- Protagonist views exposure to liquidity concern at SVB as ‘limited’
- Protagonist Therapeutics options imply 4.6% move in share price post-earnings
- Protagonist Therapeutics options imply 7.3% move in share price post-earnings
- Protagonist Therapeutics Surges 52% after Successful Phase 2 Trial
- Protagonist Therapeutics reports ‘positive’ results from FRONTIER 1 Phase 2b